Efficacy study, randomized, controlled, with CIGB-128-A injected perilesional in basal cell carcinoma in different treatment schedules
Latest Information Update: 14 Oct 2020
At a glance
- Drugs Interferon-alpha-2b/interferon-gamma (Primary)
- Indications Basal cell cancer; Carcinoma
- Focus Therapeutic Use
- Acronyms InCarbacel-V
- 05 Oct 2020 Status changed from planning to not yet recruiting.
- 05 Oct 2020 Study design changed from Parallel Assignment to Factorial Assignment.
- 18 Feb 2013 New trial record